Ocular Therapeutix To Present Clinical Data at ASCRS
Ocular Therapeutix announced multiple scientific presentations at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting being held July 23-27, 2021 in Las Vegas.
“At ASCRS, we will be presenting data on multiple programs we are advancing in the clinic as well as Dextenza (dexamethasone ophthalmic insert) 0.4 mg for intracanalicular use which is commercially available to treat postoperative ocular inflammation and pain and ReSure Sealant, an FDA-approved device to prevent wound leaks in corneal incisions following cataract surgery,” Michael Goldstein, MD, MBA, President, Ophthalmology and Chief Medical Officer of Ocular Therapeutix, said in a company news release. “The data being presented continue to support the use of Dextenza to treat postoperative ocular inflammation and pain and the ability to research the use of our proprietary hydrogel technology to potentially meet the unmet needs in the ophthalmic space, specifically in glaucoma, dry eye disease and allergic conjunctivitis. As we continue to advance and expand our pipeline, we are pleased with the results we are seeing in both the clinic and surgical settings and continue to evaluate the potential ways to best expand our versatile pipeline.”
Ocular Therapeutix Presentations at ASCRS:
Dextenza (Postoperative Ocular Inflammation and Pain):
- Title: Real World Early Physician Experience Using an Intracanalicular Dexamethasone Insert to Treat Postoperative Ocular Inflammation and Pain
Session Title: Medications (Preoperative, Postoperative, Intraoperative)
Session Date/Times: Monday, July 26, 2021 at 10:45 AM-10:50 AM PT
Location: MBCR – Level 2, Surf AB
Presenter: John D Stephens, MD
ASCRS Paper ID: 76462
- Title: Real World Time Savings on Patient Education and Call Backs Related to Post Cataract Therapy Using an Intracanalicular Dexamethasone Insert
Session Title: Medications (Preoperative, Postoperative, Intraoperative)
Session Date/Times: Monday, July 26, 2021 at 10:55 AM-11:00 AM PT
Location: MBCR – Level 2, Surf AB
Presenter: Cynthia Matossian, MD
ASCRS Paper ID: 76483
OTX-DP (dexamethasone ophthalmic insert, 0.4 mg) (Allergic Conjunctivitis):
- Title: Physician Impressions on Real World Use of Topical Corticosteroids for the Treatment of Allergic Conjunctivitis: Need for a Safer Steroid
Session Title: Ocular Surface II
Session Date/Times: Sunday, July 25, 2021 at 1:40 PM-1:45 PM PT
Location: MBCR – Level 2, Surf AB
Presenter: Lisa Nijm, JD, MD, ABO
ASCRS Paper ID: 76511
- Title: Pooled Analysis Evaluating Efficacy and Safety of an Intracanalicular Dexamethasone Insert for the Treatment of Allergic Conjunctivitis
Session Title: Ocular Surface II
Session Date/Times: Sunday, July 25, 2021 at 1:45 PM-1:50 PM PT
Location: MBCR – Level 2, Surf AB
Presenter: Jay M Rubin, MD
ASCRS Paper ID: 76531
Pipeline:
- Title: Safety and Efficacy of a Novel, Hydrogel-Based Cyclosporine Intracanalicular Insert, for the Treatment of Dry Eye Disease – Phase 1 Study
Session Title: Ocular Surface II
Session Date/Times: Sunday, July 25, 2021 at 1:35 PM-1:40 PM PT
Location: MBCR – Level 2, Surf AB
Presenter: Lee Shettle, DO
ASCRS Paper ID: 76276
- Title: Evaluating Safety, Tolerability & Efficacy of a Hydrogel-Based Intracameral Travoprost Implant in Glaucoma Patients: Phase 1 Interim Analyses
Session Title: Glaucoma – Medications
Session Date/Times: Sunday, July 25, 2021 at 2:30 PM-2:35 PM PT
Location: MBCR – Level 2, Lagoon F
Presenter: Thomas Walters, MD
ASCRS Paper ID: 76727
ReSure Sealant:
- Title: Retrospective Study Comparing the Incidence of Endophthalmitis Following Cataract Surgery in Practices with Access to Hydrogel Sealant
Session Title: Surgical Comparisons
Session Date/Times: Sunday, July 25, 2021 at 8:30 AM-8:35 AM PT
Location: MBCR – Level 2, Surf CD
Presenter: Leon Herndon, MD
Other:
- Title: Incidence of Endophthalmitis Following Cataract Surgery and Risk Factors: Retrospective Study Using the IRIS Registry
Session Title: Surgical Outcomes
Session Date/Times: Sunday, July 25, 2021 at 8:32 AM-8:37 AM PT
Location: MBCR – Level 2, Surf EF
Presenter: Michael H Goldstein, MD
ASCRS Paper ID: 76786
Investigator-Initiated Trials Presented at ASCRS:
- Title: The Restore Study: Safety and Efficacy of Dextenza for Postoperative Inflammation and Pain Following PRK
Session Title: Refractive Outcomes
Session Date/Times: Sunday, July 25, 2021 at 8:15 AM-8:20 AM PT
Location: MBCR – Level 2, Surf AB
Presenter: Brian M Shafer, MD
- Title: Intracanalicular Dexamethasone Insert for Post-Corneal Crosslinking Inflammation and Pain
Session Title: Crosslinking/Corneal Infectious Diseases
Session Date/Times: Sunday, July 25, 2021 at 1:30 PM-1:32 PM PT
Location: MBCR – Level 2, Surf EF
Presenter: Eric D Rosenberg, DO, MSE
- Title: A Retrospective Analysis of Outcomes Using an Intracanalicular Dexamethasone Implant in Post Cataract and/or Cataract-MIGS Surgery Patients
Session Title: Glaucoma- Medications
Session Date/Times: Sunday, July 25, 2021 at 2:35 PM-2:40 PM PT
Location: MBCR – Level 2, Lagoon F
Presenter: Inder P Singh, MD
- Title: Immediate Postoperative Versus Next-Day Dexamethasone Intracanalicular Insert for Inflammation and Pain Control Following Cataract Surgery
Session Title: Medications (Preoperative, Postoperative, Intraoperative)
Session Date/Times: Monday, July 26, 2021 at 10:10 AM-10:15 AM PT
Location: MBCR – Level 2, Surf AB
Presenter: Brian B Foster, MD, ABO
- Title: Postoperative Symptom Control with an Intracanalicular Dexamethasone Insert Compared to Topical Steroid Drops Following Pterygium Surgery
Cornea Posters available On-Demand
Presenter: Haroon Ilyas, MD